Plasma fibrinogen and its correlates in urban Japanese men

International Journal of Epidemiology

Volumn 25, Issue 3, 1996, Pages 521-527

  Sato, Shinichi ^a,c   Iso, Hiroyasu ^b   Naito, Yoshihiko ^a,c   Kiyama, Masahiko ^a   Kitamura, Akihiko ^a   Iida, Minoru ^a   Shimamoto, Takashi ^b   Komachi, Yoshio ^c  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Correlates; Cross sectional study; Diet; Japanese; Plasma fibrinogen; Smoking

Indexed keywords

CHOLESTEROL; FIBRINOGEN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CORONARY RISK; DIETARY INTAKE; EGG; FIBRINOGEN BLOOD LEVEL; HUMAN; JAPAN; MALE; MEAT; MILK; NORMAL HUMAN; OCTOPUS; PRIORITY JOURNAL; SEA FOOD; SHRIMP; SQUID; URBAN POPULATION; VEGETABLE;

EID: 0029945294     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/25.3.521     Document Type: Article

References (47)

1. Meade T W, North W R S, Chakrabarti R, Stirling Y, Haines A P, Thompson S G. Haemostatic function and cardiovascular death: Early results of a prospective study. Lancet 1980; i: 1050-54.
2. Meade T W, Mellows S, Brozovic M et al. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533-37.
3. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-05.
4. Stone M C, Thorp J M. Plasma fibrinogen - a major coronary risk factor. J R Coll Gen Pract 1985; 35: 565-69.
5. Kannel W B, Wolf P A, Castelli W P, D'Agostino R B. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987; 258: 1183-86.
6. Yarnell J W G, Baker I A, Sweetnam P M et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation 1991; 83: 836-44.
7. Handa K, Kono S, Saku K et al. Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis. Atherosclerosis 1989; 77: 209-13.
8. Sato S, Kato O, Kobayashi Y et al. Plasma fibrinogen and myocardial infarction: A case-control study. J Epidemiol 1994; 4(Suppl.): 79-80.
9. Meade T W, Chakrabarti R, Haines A P, North W R S, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1979; i: 153-56.
10. Balleisen L, Bailey J, Epping PH, Schulte H, van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using and menopause. Thromb Haemostas 1985; 54: 475-79.
11. Kannel W B, D'Agostino R B, Belanger A J. Fibrinogen, cigarette smoking, and the risk of cardiovascular disease: insight from the Framingham Study. Am Heart J 1987; 113: 1006-10.
12. Lee A J, Smith W C S, Lowe G D O, Tunstall-Pedoe H. The Scottish Heart Health Study. J Clin Epidemiol 1990; 43: 913-19.
13. Folsom A R, Wu K K, Davis C E, Conlan M G, Sorlie P D, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205.
14. Krobot K, Hense HW, Cremer P, Eberle E, Keil U. Determinants of plasma fibrinogen: relation to body weight, waist-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg Survey, 1989-1990. Arterioscler Thromb 1992; 12: 780-88.
15. Brunner E J, Marmot M G, White I R et al. Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II Study. Atherosclerosis 1993; 102: 195-207.
16. Yarnell J W G, Sweetnam P M, Rogers S et al. Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys. J Clin Pathol 1987; 40: 909-13.
17. Meade T W, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987; ii: 986-88.
18. Wilkes H E, Kelleher C, Meade T W. Smoking and plasma fibrinogen (Letter). Lancet 1988: i: 307-08.
19. Bonithon-Kopp C, Scarabin P-Y, Bara L, Castanier M, Jacqueson A, Roger M. Relationship between sex hormones and haemostatic factors in healthy middle-aged men. Atherosclerosis 1988; 71: 71-76.
20. Balleisen L, Assmann G, Bailey J et al. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions. Thromb Haemost 1985; 54: 721-23.
21. Moller L, Kristensen T S. Plasma fibrinogen and ischemic heart disease risk factors. Arterioscler Thromb 1991; 11: 344-50.
22. Iso H, Folsom A R, Sato S et al. Plasma fibrinogen and its correlates in Japanese and U.S. population samples. Arterioscler Thromb 1993; 13: 783-90.
23. Fehily A M, Milbank J E, Yarnell J W G, Hayes T M, Kubiki A J, Eastham R D. Dietary determinants of lipoproteins, total cholesterol, viscosity, fibrinogen, and blood pressure. Am J Clin Nutr 1982; 36: 890-96.
24. Shahar E, Folsom A R, Wu K K et al. Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993; 13: 1205-12.
25. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989; 129: 687-702.
26. Clauss A. Gennungsphysiologishe Schnellmethode sur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-46.
27. Cholesterol (Enzymatic-II): Technicon AutoAnalyser II, Method No. SE4-0065FBI. Terrytown, New York: Technicon Instruments Corporation, 1981.
28. Cholesterol (Direct): Technicon AutoAnalyser II. Method No. SE4-0026FC4. Terrytown, New York: Technicon Instruments Corporation, 1974.
29. US Department of Health and Human Services. CDC-NHLBI Lipid Standardization Program, Atlanta, Georgia: Centers for Disease Control, USA, 1980.
30. Kirkendall W M, Feinlieb M, Freis E D, Mark A L. Recommendations for human blood pressure determination by sphygmomanometers. Subcommittee of the AHA Post-graduate Education Committee. Circulation 1980; 62: 1146A-55A.
31. Hostmark A T, Bjerkedal T, Kierulf P, Flaten H, Ulshagen K. Fish oil and plasma fibrinogen. Br Med J 1988; 297: 180-81.
32. Radack K, Deck C, Huster G. Dietary supplementation with low-dose fish oils lowers fibrinogen levels: a randomized, double-blind controlled study. Ann Intern Med 1989; 111: 757-58.
33. Haglund O, Wallin R, Luostarinen R, Saldeen T. Effects of a new fluid fish oil concentrate, ESKIMO-3, on triglycerides, cholesterol, fibrinogen and blood pressure. J Intern Med 1990; 227: 347-53.
34. Schmidt E B, Varming K, Ernst E, Madsen P, Dyerberg J. Dose-response studies on the effect of n-3 polyunsaturated fatty acids on lipids and haemostasia. Thromb Haemostas 1990; 63: 1-5.
35. Flaten H, Hostmark A T, Kierulf P et al. Fish-oil concentrate: effects on variables related to cardiovascular disease. Am J Clin Nutr 1990; 52: 300-06.
36. Cobiac L, Clifton P M, Abbey M, Belling G B, Nestel P J. Lipid, lipoprotein, and hemostatic effects of fish vs fish-oil n-3 fatty acids in mildly hyperlipidemic males. Am J Clin Nutr 1991; 53: 1210-16.
37. Mortensen J Z, Schmidt E B, Nielsen A H, Dyerberg J. The effect of n-6 and n-3 polyunsaturated fatty acids on hemostasis, blood lipids and blood pressure. Thromb Haemostas 1983; 50: 543-46.
38. Roger S, James K S, Butland B K, Etherington M D, O'Brien J R, Jones J G. Effects of a fish oil supplement on serum lipids, blood pressure, bleeding time, hemostatic and rheological variables. Atherosclerosis 1987; 63: 137-43.
39. Hansen J B, Olsen J O, Wilsgard L, Osterud B. Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis. J Intern Med 1989; 225(Suppl.): 133-39.
40. Muller A D, Houwelingen A C V, van Dam-Mieras MCE, Bas B M, Hornstra G. Effect of a moderate fish intake on haemostatic parameters in healthy males. Thromb Haemostas 1989; 61: 468-73.
41. Zyglewska T, Merrill C, Conlan M G, Wu K K. N-3 fatty acids selectively inhibit fibrinogen production by cultured human hepatoma (HEPG2) cell lines (abstr). Thromb Haemostas 1991; 65: 857.
42. Kromhout D, Bosschieter E B, Coulandar C de L. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312: 1205-09.
43. Shekelle R B, Missell L V, Paul O, Shryock A M, Stamler J. Fish consumption and mortality from coronary heart disease. N Engl J Med 1985; 313: 820.
44. Norell S E, Ahlbom A, Feychting M, Pedersen N L. Fish consumption and mortality from coronary heart disease. Br Med J 1986; 293: 426.
45. Marchmann P, Sandstrom B, Jesperson J. Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb 1993; 13: 505-11.
46. Marchmann P, Sandstrom B, Jesperson J. Low-fat, high-fiber diet favorably affects several independent risk markers of ischemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr 1994; 59: 935-9.
47. Brace L D, Gittler-Buffa C, Miller G J et al. Factor VII coagulant activity and cholesterol changes in premenopausal women consuming a long-term cholesterol-lowering diet. Arterioscler Thromb 1994; 14: 1284-89.